News

Guy D’Andrea Presents at Blue Cross Blue Shield National Conference

May 2019

On May 1, Discern Managing Partner Guy D’Andrea participated in a panel presentation on the Leapfrog Group’s Hospital Value-Based Purchasing Platform. Guy joined a panel to review how Capital Blue Cross in Pennsylvania has used the Leapfrog program to measure and improve the performance of its network hospitals. The panel was part of the Blue…

Read more

Discern and NPC publish key outcomes from oncology value-based care webinar

April 2019

On March 21, the National Pharmaceutical Council (NPC) and Discern Health published the key takeaways from a “Policy Solutions for Improving Patient-Reported Measures in Oncology Value-Based Payment Programs” webinar discussion. The summary can be found here: https://www.npcnow.org/blog/loud-and-clear-key-takeaways-webinar-amplifying-patient-voice-quality-measurement.   Theresa Schmidt (tschmidt@discernhealth.com), a Director at Discern, led our team’s effort and would be excited to talk…

Read more

Discern Adds Senior Staff

April 2019

Discern has added several key members to its team to expand our staff’s capacity and the areas in which we can help clients succeed in the value-based environment. Manasi Tirodkar, PhD, joined Discern as a Director in March. She has a strong background in health services research, quality measurement, and practice transformation in primary and…

Read more

Kaitlyn Whiton promoted to Sr. Project Manager

April 2019

We are proud to announce that Kaitlyn Whiton has been promoted to Senior Project Manager. In her time at Discern, Kaitlyn has successfully managed multiple projects and played a major role in building Discern’s data analytics capabilities. She has helped conceptualize and lead projects while being an effective supervisor and mentor to project analysts. Client…

Read more

Discern Opens Washington, D.C. Office

February 2019

Discern Health has opened an office in Washington, D.C. Located one block from Union Station at 10 G Street, NE, the new office strengthens Discern’s proximity to health policy leaders and clients. The D.C. office has room for seven staff members and will complement Discern’s main office location in Baltimore. “We’re excited about this important…

Read more

National Pharmaceutical Council and Discern Health Outline Strategies for Improving Patient-Reported Measures in Oncology

February 2019

(Washington, DC, February 21, 2019) – The National Pharmaceutical Council (NPC) and Discern Health today released a study that analyzes the landscape of available patient-reported measures (PRMs) and patient-reported performance measures (PR-PMs) in oncology and offers recommendations for filling gaps in measures and removing barriers to measure implementation. The study, “Improving Patient-reported Measures in Oncology,”…

Read more

Join us for an Engaging Webinar Discussion on Patient-Reported Measures in Oncology Payment Programs

February 2019

Webinar: Amplifying the Patient Voice: Policy Solutions for Improving Patient-Reported Measures in Oncology Value-Based Payment Programs Thursday, February 28 | 2:00 p.m. – 3:30 p.m. ET In September 2018, NPC partnered with Discern Health to convene a roundtable of expert stakeholders to better understand the current state of patient-reported measurement in oncology and chart a…

Read more

Discern’s Summary of CMS’ Quality Conference

February 2019

CMS held its annual Quality Conference in Baltimore from January 29th to 31st.  About 3,000 attendees gathered to hear about CMS’ progress in improving quality and their strategy for measurement and payment innovation.  As the conference made clear, CMS is making a huge investment in quality measurement and improvement initiatives across its portfolio of programs. Several…

Read more

Valuck and Montgomery Publish Viewpoint Article in Journal of Clinical Pathways; Valuck Joins Journal’s Editorial Advisory Board

January 2019

Discern Health partner Tom Valuck, MD, JD, and Vice President Russ Montgomery, PhD, MHS, published a Viewpoint article in the December 2018 edition of the Journal of Clinical Pathways titled “Quality Measurement as a Tool for a Patient-Centered Approach to Assessing Value.” In the article, they outline how quality measures can be a tool for…

Read more

Discern Welcomes Three New Staff Members

January 2019

Discern is excited to announce the recent addition of these talented staff members to our growing team. Alexis Malfesi, Project Manager. Alexis has a deep understanding of Discern’s work from her time at Lewin Group, where she led the development and ongoing maintenance of clinical quality measures in outpatient hospital settings and worked on alternative…

Read more

Discern expands Health Economics and Outcomes Research (HEOR) Capabilities For Life Sciences clients

Health economics and outcomes research (HEOR) has long been important for health care market access outside the U.S., but it is increasingly being utilized in the U.S. as part of the movement from vol...
Learn More

About

About

Capabilities

Capabilities

Contact

Contact Us

Insights

Insights

Guy D’Andrea Speaks About Innovative Payment Models

Click here to view the VIDEO